Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.
“Approval of topical ruxolitinib fills a major gap in the treatment of atopic dermatitis: a safe, effective, and tolerable non-steroidal topical...
News
Patient risk-benefit thresholds for antibiotic use in dermatologic surgery vary widely
“This is the first study to evaluate patient preferences in a rigorous way.”
News
Skin ulcers can pose tricky diagnostic challenges
According to Dr. Alex G. Ortega-Loayza, there is a lack of gold-standard diagnostic criteria for atypical/inflammatory ulcers and a lack of...
News
Clinical genetic testing for skin disorders continues to advance
“The current staple of molecular diagnostic testing is multigene next-generation sequencing (NGS) panels, which allow you to interrogate two to...
News
Six shifts driving the future of medicine, strategist says
Contact lenses that detect glucose in tears. Capsules embedded in clothes that can be used to counteract the risk of sensitive skin conditions....
News
Targeted therapies for vascular anomalies continue to be refined
The goal of future drug therapies is to support normal growth, “so we don’t need a maximum tolerated dose,” Dr. Denise Adams said.
News
Expert shares vulvovaginal candidiasis treatment pearls
“In medical school, we learned that yeast infection in a woman presents as white, curd-like discharge, but that’s actually a minority of patients...
News
Ask about itch and joint pain in pediatric psoriasis patients, expert advises
Several studies have described an increased risk of metabolic syndrome in adolescents with pediatric psoriasis and now in prepubertal children...
News
Study evaluates OTC treatments for molluscum contagiosum
Only two of the products provided information about the number of lesions that could be treated per package.
News
Review eyes nail unit toxicities secondary to targeted cancer therapy
Paronychia and periungual pyogenic granulomas are the most common nail unit toxicities related to targeted cancer therapies and immunotherapies....
News
Hep B vaccine response varied among youth with inflammatory, autoimmune disorders
While the vaccine series provides protection in healthy individuals more than 95% of the time, a decreased response has been noted in specific...
News
Age, distance from dermatology clinic predict number of melanomas diagnosed
“Our findings reveal an important vulnerability among older patients in nonurban areas.”
News
Which AK treatment has the best long-term efficacy? A study reviews the data
The analysis “provides data that might contribute to an evidence-based framework to guide the selection of interventions for AK with proven long-...
News
Insurance coverage for vitiligo varies widely in the U.S., analysis finds
“Lack of recognition from health care insurers makes treatments both less accessible and affordable, and only further marginalizes patients with...
News
Study highlights impact of acne in adult women on quality of life, mental health
The researchers observed that most participants did not think oral antibiotics were appropriate treatments for their acne, specifically because of...